Search Results

You are looking at 51 - 60 of 60 items for :

  • "pulmonary hypertension" x
  • All content x
Clear All

Delaney, C., Cornfield, D. N.: Risk factors for persistent pulmonary hypertension of the newborn. Pulm. Circ., 2012, 2 , 15–20. Cornfield D. N. Risk factors for persistent pulmonary

Open access

dysplasia: pulmonary hypertension and beyond. Curr. Opin. Pediatr., 2013, 25 , 329–337. Abman S. H. Pulmonary vascular disease in bronchopulmonary dysplasia: pulmonary hypertension and

Open access

55 579 585 Dhillon, S., Kaker, A., Dosanjh, A. és mtsai: Irreversible pulmonary hypertension associated with the use of interferon

Restricted access
Orvosi Hetilap
Authors: István Czuriga, Attila Borbély, Dániel Czuriga, Zoltán Papp, and István Édes

Guazzi, M., Vicenzi, M., Arena, R., et al.: Pulmonary hypertension in heart failure with preserved ejection fraction: a target of phosphodiesterase-5 inhibition in a 1-year study. Circulation, 2011, 124 , 164

Restricted access
Interventional Medicine and Applied Science
Authors: Adam Hatzidakis, Emmanuel Touloupakis, Stavros Charalambous, Despoina Reppa, and Efstratios Karagiannakidis

exclude the aneurysmal sac from arterial circulation [ 8 ]. Emerging endovascular techniques show promising results in the management of IIAA. Case Report An 88-year-old male patient with a history of pulmonary hypertension

Open access
Interventional Medicine and Applied Science
Authors: Kamal Dua, Shakti Dhar Shukla, Terezinha de Jesus Andreoli Pinto, and Philip Michael Hansbro

aerosol dispersion performance, which can reach the lower airways and can reduce the inflammation in various conditions like acute lung injury, pulmonary hypertension, and pulmonary endothelial diseases including COPD by targeting Nrf2/Keap-1 pathway

Open access

, Quignard JF : T-type calcium channels are involved in hypoxic pulmonary hypertension . Cardiovasc. Res. 103 ( 4 ), 597 – 606 ( 2014 ) 10.1093/cvr/cvu166 6

Restricted access
Physiology International
Authors: Zs Major, R Kirschner, N Medvegy, K Kiss, GM Török, G Pavlik, G Simonyi, Zs Komka, and M Medvegy

, Lewis GD : Exercise-induced pulmonary hypertension: physiological basis and methodological concerns . Am. J. Respir. Crit. Care Med. 187 , 576 – 583 ( 2013 ) 10.1164/rccm.201211-2090CI

Restricted access

, 36 , 42 , 47 ). In addition, SOCCs have been shown to be associated with several cardiovascular diseases, such as idiopathic pulmonary hypertension, hypoxic pulmonary vasoconstriction, cardiac hypertrophy, aneurysm, and arrhythmia ( 26 , 61

Restricted access
Interventional Medicine and Applied Science
Authors: Anand Maurya, Anurag Kumar Singh, Gaurav Mishra, Komal Kumari, Arati Rai, Bhupesh Sharma, Giriraj T. Kulkarni, and Rajendra Awasthi

containing beclomethazone nanoparticles US19985747001 Drug delivery [ 192 ] Estradiol metabolites nanoparticle for pulmonary hypertension therapy US

Open access